SBIR-STTR Award

Amplification Of Nucleic Acid In Immobilized Blood
Award last edited on: 4/29/02

Sponsored Program
SBIR
Awarding Agency
NIH : NHLBI
Total Award Amount
$99,993
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Marilyn J Stapleton

Company Information

Gene Tec Corporation

205 Winterberry Ridge Drive
Durham, NC 27713
   (678) 764-6240
   N/A
   www.genetecproducts.com
Location: Single
Congr. District: 01
County: Durham

Phase I

Contract Number: 1R43HL058320-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1997
Phase I Amount
$99,993
This application proposes the use of a methodology, immobilized sample amplification (ISA), to achieve PCR amplification of nucleic acids in clinical samples, eliminating the need for a nucleic acid purification step. Preliminary data are presented that indicate that PCR amplification of unfixed, immobilized blood cells can be achieved. The goal of this Phase I application is to demonstrate that ISA is a sensitive and reproducible method to detect viral RNA in blood, using the equine infectious anemia virus (EIAV) as a paradigm. For this purpose, the cellular and plasma portion of blood will be immobilized on a filtration membrane. The method will utilize a proprietary disposable device, the Gene Flo chamber, to collect a very small amount of blood and dry it into a reaction chamber where amplification and detection of the target sequences takes place.

Thesaurus Terms:
blood test, communicable disease diagnosis, diagnosis design /evaluation, polymerase chain reaction equine infectious anemia virus, human immunodeficiency virus, virus RNA human tissueNational Heart, Lung and Blood Institute (NHLBI)

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----